LIGAND PHARMACEUTICALS INCORPORATED
Net Cash Flow Breakdown
Total Cash from Operations: $522.6M
| Line Item | Value | % of Total |
|---|---|---|
| Capital Expenditures | $610.5K | 0.1% |
| Business Acquisitions | $4.0M | 0.8% |
| Other Investing | $286.7M | 54.9% |
| Net Cash Flow | $231.3M | 44.3% |
Net Cash Flow Breakdown
Total Cash from Operations: $522.6M
| Line Item | Value | % of Total |
|---|---|---|
| Capital Expenditures | $610.5K | 0.1% |
| Business Acquisitions | $4.0M | 0.8% |
| Other Investing | $286.7M | 54.9% |
| Net Cash Flow | $231.3M | 44.3% |